Patent Grant
8614263
The present invention pertains to endodontic sealant compositions and particularly to non-biodegradable endodontic sealant compositions.
Endodontic sealants are used to seal portions of dental roots and are often used for root canal treatment. In order to be effective, endodontic sealants should be non-toxic to the patient and biocompatible with surrounding tissue, tooth, and bone. Many clinical applications of endodontic sealant exist in endodontic and pedodontic practice. Uses of endodontic sealant for tooth root treatment include, for example, sealing of perforations, furcation repair, pulp capping, apexification, repairing root that is damaged during a root canal procedure, and treating root resorption. Endodontic sealants may also be used as retrograde filling materials or pulpotomy agents.
Biodegradable dental compositions are often used as bone replacement materials, such as bone grafts, because the compositions degrade and allow new bone or other tissue to substantially replace the composition. For example, U.S. Pat. No. 6,787,584 discloses a degradable dental composition which is intended to interact with surrounding tissues to promote re-growth of tissue and bone. For endodontic sealants, however, biodegradability is a disadvantage. Rather, one of the main purposes of endodontic sealants is to provide a lasting seal which remains in place and is not re-absorbed by the body. Non-biodegradability ensures that the affected area remains sealed off from surrounding tissue, tooth, and bone. One of the advantages of non-biodegradability, for example, is that bacteria and other infectious organisms are prevented from migrating into the root canal cavity or from the root canal into bone.
Efforts have been made to provide endodontic sealants which are non-biodegradable. For example, ProRoot® MTA (Mineral Trioxide Aggregate), sold by Dentsply, is used as a non-biodegradable endodontic sealant. In its clinical application, the MTA powder is mixed with water to provide a grainy mixture, and is then delivered and gently packed into the desired area. MTA is biocompatible and provides an effective sealant for tooth roots. However, MTA requires moisture to solidify or set, with setting times varying from approximately 3.5 hours to approximately 5 hours. Due to the long setting time, post-operative bleeding may cause portions of the sealant to be lost from the site of application. Also, in applications where a moist cotton pellet is placed on top of the MTA to ensure proper setting, a second treatment is required to remove the pellet, thus causing discomfort and inconvenience for the patient. Accordingly, it is desirable to provide an endodontic sealant that is non-biodegradable and requires a shorter setting time for the sealant to solidify.
The present invention provides a non-biodegradable endodontic sealant composition. The sealant composition comprises the reaction product of a first paste and a second paste. At least one of the first paste or the second paste comprises a biocompatible hydrophilic monomer comprising unmodified 2-hydroxyethyl methacrylate. At least one of the first paste or the second paste comprises bioglass. The first paste comprises a first polymerizing agent and the second paste comprises a second polymerizing agent. The biocompatible hydrophilic monomer comprises unmodified 2-hydroxyethyl methacrylate (also known as “HEMA”).
The present invention further provides a method for making the non-biodegradable sealant composition, which comprises preparing the first paste and second paste and combining the two pastes together. The two pastes are combined under conditions to achieve a polymerization reaction. The polymerization reaction is initiated by a reaction between the first polymerizing agent and the second polymerizing agent. In a preferred embodiment, the combining step further comprises conditions to achieve a setting time that is in a range of about 1 minute to about 1 hour.
The present invention further provides a method for treating humans having an affected area of tooth root, comprising administering the sealant composition to the affected area. The non-biodegradable sealant composition is preferably administered to an area where tissue, tooth, or bone are not intended to re-grow.
The present invention is directed to a non-biodegradable endodontic sealant composition; a method for making the sealant composition; and a method for treating humans having an affected area of tooth root. The sealant composition comprises the reaction product of a first paste and a second paste. At least one of the first paste or the second paste comprises a biocompatible hydrophilic monomer. At least one of the first paste or the second paste comprises bioglass. The first paste comprises a first polymerizing agent and the second paste comprises a second polymerizing agent.
As used herein, the biocompatible hydrophilic monomer comprises unmodified 2-hydroxyethyl methacrylate (also known as “HEMA”). As used herein, the term “unmodified” means that additional substituents, such as, for example, degradable substitutents, are not bonded to the HEMA. The bioglass comprises calcium-based glass. The bioglass may include, for example, at least one of silicon dioxide, calcium oxide, sodium oxide, phosphorus pentoxide, calcium silicate, barium sulfate, aluminum oxide, or a combination thereof. Preferably, the bioglass comprises silicon dioxide, calcium oxide, and phosphorus pentoxide. The first polymerizing agent of the first paste preferably comprises an initiator and the second polymerizing agent of the second paste preferably comprises an accelerator. Most preferably, the initiator comprises benzoyl peroxide, and the accelerator comprises at least one of p-toluidine, p-toluenesulfinate, or a combination thereof.
In a preferred embodiment, the first paste comprises a biocompatible hydrophilic monomer, bioglass, and a first polymerizing agent; and the second paste comprises a biocompatible hydrophilic monomer, bioglass, and a second polymerizing agent. In alternative embodiments, the only constituents that are provided in separate pastes are the first polymerizing agent and the second polymerizing agent (e.g., the first paste comprises a biocompatible hydrophilic monomer, bioglass, and a first polymerizing agent; and the second paste comprises a second polymerizing agent). In other alternative embodiments, the first paste comprises a first polymerizing agent and any of a biocompatible hydrophilic monomer, and/or bioglass; and the second paste comprises a second polymerizing agent and any of a biocompatible hydrophilic monomer, and/or bioglass.
In a preferred embodiment, at least one of the first paste and second paste further comprises at least one antioxidant. One of the benefits of the antioxidant is that it reduces any toxicity of the sealant, such as any cytotoxicity of HEMA. The antioxidant may include, for example, at least one of ascorbic acid, glutathione, alpha-tocopherol, or a combination thereof, and most preferably comprises ascorbic acid.
The sealant composition may also comprise additional constituents which adjust the viscosity of the composition. For example, in an alternative embodiment, at least one of the first paste or the second paste comprises at least one polymerizable dimethacrylate monomer (e.g., triethylene glycol dimethacrylate). One benefit of dimethacrylates is that they may be used to increase or decrease the viscosity of the sealant composition. The desired viscosity depends on the particular use of the composition and can readily be determined by an artisan.
The sealant composition may also comprise additional constituents which adjust the radiopacity of the sealant, so that the sealant can be made visible by x-rays or other types of radiologic imaging systems. For example, in an alternative embodiment, at least one of the first paste or the second paste may comprise triphenylbismuth carbonate, which renders the sealant composition radiopaque.
The present invention also provides a method for making the non-biodegradable sealant composition, which comprises preparing the first paste and second paste and combining the two pastes together. The two pastes are combined under conditions to achieve a polymerization reaction which is initiated by a reaction between the first polymerizing agent and the second polymerizing agent. The polymerization reaction preferably comprises a free radical initiated addition polymerization. The first paste, second paste, and reaction product of the two pastes may have wide ranges of viscosities, depending on the amounts and types of constituents that are used.
In a preferred embodiment, the combining step comprises conditions which achieve a setting time that is in a range of about 1 minute to about 1 hour. The setting time can be varied by varying the reactants used in the composition. As used herein, “setting time” refers to the amount of time measured from the time that the two pastes are combined to the time that the reaction product of the combined pastes becomes solidified. The preferred setting time of about 1 minute to about 1 hour is substantially shorter than the setting time of prior art systems. A shorter setting time provides added convenience and comfort to a patient, as the patient does not have to wait as long for the composition to solidify and likely does not have to have any additional procedure performed before the composition solidifies. In a preferred embodiment, adding moisture to the composition is not required in order for the composition to set.
The present invention also provides a method for treating humans having a voided region into which no re-growth will occur, comprising administering the sealant composition to the voided region. The preferred use of the sealant composition is to seal portions of dental roots, preferably for root canal treatment. There are many clinical applications for the sealant composition in both endodontic and pedodontic practice, including, for example, sealing of perforations, furcation repair, pulp capping, apexification, repairing root that is damaged during a root canal procedure, and treating root resorption. The sealant composition may also be used as retrograde filling materials or pulpotomy agents.
The sealant composition of the present invention is preferably administered to an area where tissue, tooth, or bone are not intended to re-grow. The sealant composition is non-biodegradable, which makes it especially suitable for applications where the sealant is intended to provide a lasting seal and not be re-absorbed by the body. Non-biodegradability helps to ensure that the affected area remains sealed off from surrounding tissue, tooth, and bone. One of the advantages of non-biodegradability, for example, is that bacteria and other infectious organisms are prevented from migrating into the root canal cavity or from the root canal into bone.
Exemplary compositions according to the present invention are shown in the following examples. The amounts listed below were used in the particular compositions set forth in the Examples, but those amounts may vary over a range, as an artisan would readily recognize.
According to a first exemplary embodiment, the Powder Composition (modified from Bioglass) included the components listed in Table 1.
Paste 1 and Paste 2 included the following components:
Paste 1: 5 ml HEMA+0.05 g Benzoyl Peroxide
Paste 2: 5 ml HEMA+0.05 ml N N dimethyl-p-Toluidine
Paste 1, Paste 2, and the Powder Composition of Table 1 were combined in the following amounts: 100 microliters (ul) of Paste 1+100 ul of Paste 2+0.312 g of Powder Composition. The setting time was 4 minutes.
According to a second exemplary embodiment, the Powder Composition (modified from Bioglass) included the same components as those listed in Table 1.
Paste 1 and Paste 2 included the following components:
Paste 1: 5 ml HEMA+0.04 g Benzoyl Peroxide
Paste 2: 5 ml HEMA+0.04 ml N N dimethyl-p-Toluidine
Paste 1, Paste 2, and the Powder Composition of Table 1 were combined in the following amounts: 100 ul Paste 1+100 ul Paste 2+0.67 g Powder Composition. The setting time was 6-7 minutes.
According to a third exemplary embodiment, the Powder Composition (modified from Bioglass) included the same components as those listed in Table 1.
Paste 1 and Paste 2 included the following components:
Paste 1: 5 ml HEMA+0.03 g Benzoyl Peroxide
Paste 2: 5 ml HEMA+0.02 ml N N dimethyl-p-Toluidine+0.05 g toluenesulfinate
Paste 1, Paste 2, and the Powder Composition of Table 1 were combined in the following amounts: 100 ul Paste 1+100 ul Paste 2+0.67 g Powder Composition. The setting time was 3 minutes.
Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the invention.
This application claims priority of U.S. Provisional Patent Application Ser. No. 61/150,498 filed Feb. 6, 2009, which is incorporated by reference herein in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3575946 | Chromecek et al. | Apr 1971 | A |
| 3925895 | Kliment et al. | Dec 1975 | A |
| 4103002 | Hench et al. | Jul 1978 | A |
| 4159358 | Hench et al. | Jun 1979 | A |
| 4171544 | Hench et al. | Oct 1979 | A |
| 4189325 | Barrett et al. | Feb 1980 | A |
| 4234972 | Hench et al. | Nov 1980 | A |
| 4478904 | Ducheyne et al. | Oct 1984 | A |
| 4544359 | Waknine | Oct 1985 | A |
| 4547531 | Waknine | Oct 1985 | A |
| 4775646 | Hench et al. | Oct 1988 | A |
| 4851046 | Low et al. | Jul 1989 | A |
| 5074916 | Hench et al. | Dec 1991 | A |
| 5415547 | Torabinejad et al. | May 1995 | A |
| 5810595 | Mallow | Sep 1998 | A |
| 6051247 | Hench et al. | Apr 2000 | A |
| 6787584 | Jia et al. | Sep 2004 | B2 |
| 7275933 | Jia et al. | Oct 2007 | B2 |
| 7331789 | Karmaker et al. | Feb 2008 | B2 |
| 20020120033 | Jia et al. | Aug 2002 | A1 |
| Number | Date | Country |
|---|---|---|
| WO 2004103425 | Dec 2004 | WO |
| Entry |
|---|
| Cycotoxicity evaluation of a new radiopaque resin additive—triphenyl bismuth, H.R. Rawls et al. Den Mater 8:54-59, Jan. 1992. |
| Yosef Nahmias et al., “Mineral Trioxide Aggregate (MTA) and its Uses”, The First Electronic Endodontic Magazine 2007, http://www/endoweb.com/dentist/nah—ber1.htm. |
| Jin-Seon Song et al., “Chemical Analysis of Powder and Set Forms of Portland Cement, Gray ProRoot MTA, White ProRoot MTA, and Gray MTA-Angelus”, Oral Surg Oral Med Oral Pathol Oral Radiol Endod., (2006), vol. 102, No. 6, pp. 809-815. |
| U. I. Walther et al., “Antioxidative Vitamins Decrease Cytotoxicity of HEMA and TEGDMA in Cultured Cell Lines”, Archives of Oral Biology (2004), vol. 49, pp. 125-131. |
| Number | Date | Country | |
|---|---|---|---|
| 20100203482 A1 | Aug 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61150498 | Feb 2009 | US |
